These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36316684)

  • 1. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer.
    Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M
    Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
    Yang J
    Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 6. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer.
    Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C
    Front Oncol; 2022; 12():878546. PubMed ID: 35712475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
    Wang M; Li C; Liu Y; Wang Z
    Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
    Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer.
    Ju Y; Wang Z; Wang Q; Jin S; Sun P; Wei Y; Zhu G; Wang K
    J Cell Mol Med; 2024 Aug; 28(15):e18579. PubMed ID: 39086142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 15. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
    Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
    Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
    Fang W; Wan D; Yu Y; Zhang L
    Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].
    Li X; He J; Yu M; Zhang W; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
    Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
    Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.